| Code | 3123E | ||||||||||
| MA number | 18/0080/21-S | ||||||||||
| Product Form: | tbl flm 120x50 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.04.2021 |
| Validity: | 04.04.2026 |
| MA renewed: | Renewal application submitted |
| PIL: |
PIL_Adimuplan 50 a 100 mg_02.2023.pdf
|
| SPC: |
SPC_Adimuplan 50 a 100 mg_02.2023.pdf
|
| Safety feature | Yes |
| Data update: | 23.02.2023 |
